Unstable Angina Pectoris Clinical Trial
Official title:
Safety and Efficacy of Low Temperature Contrast for the Treatment of PCI-related Myocardial Injury in Patients With Unstable Angina Pectoris (LOTA-I)
Percutaneous coronary intervention (PCI) has become one of the main treatments for rapid recovery of revascularization in patients with coronary heart disease (CHD). PCI has some advantages, such as easy operation, small trauma and rapid recovery. It can significantly improve myocardial ischemic symptom and reduce the incidence of cardiovascular adverse events in CHD patients. However, many studies have found that the incidence of PCI-related myocardial injury is relatively high, and affect the efficacy of PCI and prognosis in patients with unstable angina pectoris (UAP). A meta-analysis of a total of 7578 patients with UAP from 15 studies who underwent PCI was found to have a 28.7% increase in myocardial biomarkers after PCI. The objective of this randomized control trial is to gain a clinical insight on the use of low temperature contrast for the treatment of PCI-related myocardial injury in UAP patients. The primary objective is assess efficacy and safety of low temperature contrast for the treatment of PCI-related myocardial injury in UAP patients.
The current study is designed as a multicenter, randomized and prospective study aiming to compare the change in levels of myocardial injury biomarkers (such as TNI and CK-MB) between low temperature contrast group and room temperature contrast group. Based on previous study, the incidence rate of PCI-related myocardial injury is 28.7% in UAP patients undergoing PCI. And in our study the expected incidence rate of PCI-related myocardial injury is up to 14.3% in UAP patients undergoing PCI after treatment with low temperature contrast. Moreover, the investigators estimated 10% loss follow-up of these patients in each arm. As a result, a total of 440 UAP patients were required, and with 220 patients per group as a ratio of 1:1 randomization. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT02612116 -
Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study
|
Phase 4 | |
Active, not recruiting |
NCT02508714 -
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
|
N/A | |
Completed |
NCT02939248 -
Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
|
Phase 4 | |
Active, not recruiting |
NCT02175706 -
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
|
N/A | |
Completed |
NCT01377402 -
ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study
|
N/A | |
Completed |
NCT00521976 -
Risk Markers in the Acute Coronary Syndromes
|
||
Completed |
NCT02144090 -
Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study
|
N/A | |
Completed |
NCT00627744 -
Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
|
Phase 4 | |
Completed |
NCT00990262 -
Rule Out Myocardial Infarction by Computer Assisted Tomography
|
N/A | |
Enrolling by invitation |
NCT04008173 -
The International Survey of Acute Coronary Syndromes-ARCHIVES
|
||
Withdrawn |
NCT02165670 -
BASIC VALIDATE Coronary Stent Registry
|
||
Completed |
NCT01293097 -
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
|
Phase 4 | |
Completed |
NCT01066650 -
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente
|
Phase 4 | |
Completed |
NCT02747329 -
A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT
|
N/A | |
Completed |
NCT02939235 -
Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
|
Phase 4 | |
Not yet recruiting |
NCT03155971 -
PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
|
N/A | |
Recruiting |
NCT04575207 -
The Flash FFR Ⅱ Study
|
N/A | |
Terminated |
NCT02235753 -
High-intensity Exercise After Acute Cardiac Event (HITCARE)
|
N/A | |
Completed |
NCT02007187 -
Danhong Injection in the Treatment of Unstable Angina Pectoris
|
Phase 4 |